نتائج البحث

Post Market Clinical Evaluation for the Safety of Endoscopic Devices and Accessories دراسات الأجهزة الطبية

An observational study to monitor 2- Combination regimen's patterns of oral hypoglycaemic agents in Type 2 diabetic patients in daily clinical practice in Saudi Arabia قائمة الدراسات السريرية المسجلة على الادوية

سحب تشغيلتين من مستحضر (‎FELOCAINE (3% Prilocaine with Felypressin 0.03 IU/ML من إنتاج شركة RADIANT PARENTERAL LTD FOR ZYMETH - INDIA)) السحب و الإستدعاءات

A Phase 3, randomised, double-blind, parallel-group, event-driven, cardiovascular safety study with BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity with established cardiovascular disease (CVD) or chronic kidney disease, and/or at least two weight related complications or risk factors for CVD قائمة الدراسات السريرية المسجلة على الادوية

(SG-1909-105-H) Recommendations for increasing the efficacy and reliability of FreeStyle Libre 14 Day Flash Glucose Monitoring) التقارير الأسبوعية للمركز الوطني لبلاغات الأجهزة والمنتجات الطبية

A 20-week Study Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients Uncontrolled on NPH Insulin قائمة الدراسات السريرية المسجلة على الادوية

"CLCZ696B2401-TRANSITION (A multicenter, randomized, open label, parallel group studycomparing pre-discharge and posT-discharge tReatmentinitiation with LCZ696 in heArt failure patieNtS withreduced ejectIon-fracTion hospItalized for an acutedecOmpensation eveNt (ADHF)" قائمة الدراسات السريرية المسجلة على الادوية

A phase 3, multi-center, open-label, randomized study of oral ABL001 versus bosutinib in patients with Chronic Myelogenous Leukemia in chronic phase (CML-CP), previously treated with 2 or more tyrosine kinase inhibitors قائمة الدراسات السريرية المسجلة على الادوية

Open Label, Multinational, Multicenter, Real World Treatment Study of Single Agent AZD9291 for Patients with Advanced/Metastatic Epidermal Growth Factor Receptor (EGFR)T790M Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) Who Have Received Prior Therapy with an EGFR Tyrosine Kinase Inhibitor(EGFR-TKI) قائمة الدراسات السريرية المسجلة على الادوية

An Open-Label, Randomized, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in Pediatric Subjects Aged 10 to Less Than 18 Years for the Treatment of Relapsing-Remitting Multiple Sclerosis, With Optional Open-Label Extension قائمة الدراسات السريرية المسجلة على الادوية

عرض 141 - 150 من 2188